Literature DB >> 7237831

High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man--evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipase.

M R Taskinen, E A Nikkilä.   

Abstract

High density lipoprotein subfractions HDL2 and HDL3 were separated from plasma of 22 normolipidemic healthy human subjects and analyzed for cholesterol, triglyceride, phospholipid and protein. In the same subjects the heparin-releasable lipoprotein lipase activity was assayed from biopsies of adipose tissue and skeletal muscle. A significant inverse correlation was found between the plasma concentrations of HDL2 and HDL3 (4= -0.55, p less than 0.01). The HDL2 cholesterol and HDL2 phospholipid levels were negatively correlated with HDL3 protein levels. The total HDL2 and HDL2 cholesterol, phospholipid and protein concentrations were all positively correlated with lipoprotein lipase activity of both adipose tissue and skeletal muscle. In contrast, the corresponding HDL3 values did not show any correlation with adipose tissue lipoprotein lipase but the HDL3 cholesterol, triglyceride and protein levels were inversely correlated with skeletal muscle lipoprotein lipase activity. The results suggest that plasma HDL2 and HDL3 concentrations are reciprocally regulated by the activity of lipoprotein lipase. THe data are compatible with a concept proposing conversion of HDL3 to HDL2 through assimilation of cholesterol, phospholipids and apoproteins from triglyceride-rich lipoproteins during their degradation by lipoprotein lipase. Particularly the concentration of the HDL2 is closely related to the rat of intravascular lipolysis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7237831     DOI: 10.1016/0009-8981(81)90455-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

Review 1.  Anabolic-androgenic steroid effects on endocrinology and lipid metabolism in athletes.

Authors:  M Alén; P Rahkila
Journal:  Sports Med       Date:  1988-12       Impact factor: 11.136

Review 2.  Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis.

Authors:  J L Durstine; P W Grandjean; P G Davis; M A Ferguson; N L Alderson; K D DuBose
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

3.  Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.

Authors:  Ronald B Goldberg; Marinella Temprosa; Lisa Mele; Trevor Orchard; Kieren Mather; George Bray; Edward Horton; Abbas Kitabchi; Jonathan Krakoff; Santica Marcovina; Leigh Perreault; Neil White
Journal:  Metabolism       Date:  2015-12-02       Impact factor: 8.694

4.  Study of Common Genetic Variant S447X in Lipoprotein Lipase and Its Association with Lipids and Lipoproteins in Type 2 Diabetic Patients.

Authors:  A A Momin; M P Bankar; G M Bhoite
Journal:  Indian J Clin Biochem       Date:  2015-10-13

5.  The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis.

Authors:  K Tsutsumi; Y Inoue; A Shima; K Iwasaki; M Kawamura; T Murase
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

6.  Effect of pindolol on serum lipids and lipid metabolizing enzymes.

Authors:  A Lehtonen; E Hietanen; J Marniemi; P Peltonen; J Niskanen
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

7.  Regulation of lipoprotein lipase in primary cultures of isolated human adipocytes.

Authors:  P A Kern; S Marshall; R H Eckel
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

8.  The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion.

Authors:  Shu-Fen Wung; Medha V Kulkarni; Clive R Pullinger; Mary J Malloy; John P Kane; Bradley E Aouizerat
Journal:  Lipids Health Dis       Date:  2006-07-05       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.